Migraine Pill’s Price Tag Under the Microscope: Atogepant Cost-Effectiveness Tested in Taiwan
A Taiwanese cost-utility analysis finds atogepant's cost-effectiveness for episodic migraine prevention hinges on quality-of-life assumptions and willingness-to-pay thresholds.
